These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25619678)

  • 1. Depersonalization/derealization disorder after exposure to mefloquine.
    McEvoy K; Anton B; Chisolm MS
    Psychosomatics; 2015; 56(1):98-102. PubMed ID: 25619678
    [No Abstract]   [Full Text] [Related]  

  • 2. Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student.
    Dietz A; Frölich L
    Pharmacopsychiatry; 2002 Sep; 35(5):200-2. PubMed ID: 12237793
    [No Abstract]   [Full Text] [Related]  

  • 3. Alice in wonderland syndrome in major depressive disorder.
    Bui E; Chatagner A; Schmitt L
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352j.e16-352.e16. PubMed ID: 20686154
    [No Abstract]   [Full Text] [Related]  

  • 4. A preliminary evaluation of repeated exposure for depersonalization and derealization.
    Weiner E; McKay D
    Behav Modif; 2013 Mar; 37(2):226-42. PubMed ID: 23118274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 6. Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation: A Case Report.
    Del Casale A; Rapinesi C; Kotzalidis GD; Sorice S; Padovano A; Gentile G; Angeletti G; Ferracuti S; Sani G; Pompili M; Simmaco M; Girardi P
    J ECT; 2017 Sep; 33(3):e27-e29. PubMed ID: 28570499
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
    Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
    Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram-associated spontaneous ejaculations.
    Virit O; Savas HA
    J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Citalopram].
    Taéron C
    Rev Infirm; 2008 Nov; (145):47-9. PubMed ID: 19044198
    [No Abstract]   [Full Text] [Related]  

  • 12. The STAR*D trial: the 300 lb gorilla is in the room, but does it block all the light?
    Hatcher S
    Evid Based Ment Health; 2008 Nov; 11(4):97-9. PubMed ID: 18952951
    [No Abstract]   [Full Text] [Related]  

  • 13. Palpebral twitching in a depressed adolescent on citalopram.
    Rojas VM; Silva R
    J Child Adolesc Psychopharmacol; 2001; 11(3):295-9. PubMed ID: 11642480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.
    Yu AP; Xie J; Bensimon A; Parikh K; Wu EQ; Ben-Hamadi R; Blum S; Haim Erder M
    J Med Econ; 2010; 13(4):599-609. PubMed ID: 20879834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
    Bär KJ; Schuhmacher A; Höfels S; Schulz S; Voss A; Yeragani VK; Maier W; Zobel A
    J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
    Uguz F; Sahingoz M
    Clin Neuropharmacol; 2014; 37(4):125-7. PubMed ID: 24992087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
    Landowski J
    Psychiatr Pol; 2000; 34(3 Suppl):1-8. PubMed ID: 11055187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depersonalization--current data].
    Khazaal Y; Zimmermann G; Zullino DF
    Can J Psychiatry; 2005 Feb; 50(2):101-7. PubMed ID: 15807226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.